News & Blog

Tag Archives: glioblastoma multiforme

Defeat GBM Research Collaborative: Two-Year Progress Report

Where We’ve Been & Where We’re Going: Past Progress and Future Developments Glioblastoma (GBM) is the most common, complex, treatment-resistant, and deadliest type of brain cancer. The pursuit of new and more effective treatments for GBM patients addresses an area of urgent, high-unmet medical need given the lack of effective treatment options currently available. GBM […]

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

Latest Brain Tumor Research News from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology

As has been our custom, we like to provide a recap of the some of the most intriguing news every year that comes out of the Annual Scientific Meeting of the Society for Neuro-Oncology (SNO), the preeminent scientific conference dedicated specifically to brain tumors and brain cancer, which was convened this year on November 20th- 22nd […]

Share